EGFR and breast carcinoma: Moreover, as the ESMA CAR-interacting endogenous receptors are also expressed on NK cells [54,62], their applicability in a CAR NK cell setting should be evaluated, especially considering recent promising in vivo studies of EGFR-directed CAR NK cells against glioblastoma and breast cancer brain metastasis [63,64].